Norway to reimburse liquid-based cytology for cervical cancer screening
This article was originally published in Clinica
Executive Summary
The Norwegian cervical screening programme has begun reimbursing liquid-based cytology (LBC), paving the way for this technique to replace the traditional Pap test. During a Pap test, a cervical sample is smeared onto a slide and then analysed. LBC samples are collected in a similar way, but the cervical cells are rinsed off into a vial of preservative fluid before being sent to the lab. The method could reduce the number of inadequate samples and, consequently, the number of women who need to return for repeat testing. The UK converted to LBC testing in 2008 (www.clinica.co.uk, 9 May 2008). Available LBC tests include Hologic's ThinPrep and Source BioScience Healthcare's SurePath system.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.